Plant Comparison

Greater Celandine vs Meadowsweet

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AGreater CelandineChelidonium majusPapaveraceaeFull monograph →
Plant BMeadowsweetFilipendula ulmariaRosaceaeFull monograph →

At a glance

Greater Celandine and Meadowsweet: they share 12 indicated uses (arthritis / joint pain, back pain, cancer (anticancer research), …); 5 pharmacological actions in common.

Greater CelandineMeadowsweet
Constituents33
Pharmacological actions68
Indicated uses1516
Safety notes22
Cited sources1417
Indicated uses
Only Greater Celandine
BloatingLiver supportWarts
Shared (12)
Arthritis / joint painBack painCancer (anticancer research)HeadacheIndigestionInfection (general)Inflammation (general)Menstrual crampsMuscle spasmPain (general)Skin irritationWounds
Only Meadowsweet
Acid refluxSwelling / fluid retentionUrinary supportUrinary tract infection (UTI)
Pharmacological actions
Only Greater Celandine
Choleretic / cholagogue (bile flow)
Shared (5)
Analgesic (pain relief)Anti-inflammatoryAnticancer (preclinical)AntimicrobialAntispasmodic
Only Meadowsweet
AntioxidantDiureticGastroprotective

Evidence face-off — shared uses

ConditionGreater CelandineMeadowsweetVerdict
Arthritis / joint pain1/101/10Comparable evidence
Back pain1/101/10Comparable evidence
Cancer (anticancer research)2/102/10Comparable evidence
Headache1/101/10Comparable evidence
Indigestion1/101/10Comparable evidence
Infection (general)1/101/10Comparable evidence
Inflammation (general)1/101/10Comparable evidence
Menstrual cramps1/101/10Comparable evidence
Muscle spasm1/101/10Comparable evidence
Pain (general)1/101/10Comparable evidence
Skin irritation1/101/10Comparable evidence
Wounds1/101/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Isoquinoline alkaloids (chelidonine, coptisine, berberine, sanguinarine, chelerythrine)[4]

The biologically active and toxicologically important constituents.

AlkaloidsBerberine
Flavonoids and phenolic acids[4]

Antioxidant constituents.

Phenolic acidsFlavonoids
Orange latex (alkaloid-rich sap)[4]

The caustic sap used traditionally on warts.

Alkaloids
Salicylates (methyl salicylate, salicylic acid derivatives)[1, 4]

Historically the source of aspirin's chemical inspiration; provide the plant's analgesic and anti-inflammatory activity, buffered by co-occurring mucilage and tannins.

Flavonoids (quercetin, rutin, hyperoside)[1]

Antioxidant constituents contributing to the plant's anti-inflammatory and gastroprotective effects.

FlavonoidsQuercetinRutin
Tannins and essential oil[1]

Contribute to astringency and the characteristic sweet almond-like fragrance.

TanninsEssential (volatile) oil

Pharmacological Actions

Analgesic (pain relief)[4]

Anti-inflammatory, antimicrobial and analgesic (preclinical)

Anti-inflammatory[1, 4, 8]

Anti-inflammatory, antimicrobial and analgesic (preclinical)

Anticancer (preclinical)[6, 7, 12]
Antimicrobial[1, 3, 4, 10]

Anti-inflammatory, antimicrobial and analgesic (preclinical)

Antispasmodic[4]

Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety

Choleretic / cholagogue (bile flow)[4]

Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety

Analgesic (pain relief)[5, 14, 15, 16]
Anti-inflammatory[1, 3, 4, 5, 14, 15, 16]
Anticancer (preclinical)[2, 12]
Antimicrobial[14, 15, 16]
Antioxidant[1, 6, 7, 14, 15, 16]
Antispasmodic[14, 15, 16]

Antispasmodic (cramp easing)

Diuretic[9, 11, 14, 15, 16]
Gastroprotective[1, 14, 15, 16]

Traditional & Indicated Uses

Arthritis / joint pain[4]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Back pain[4]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Back pain
Bloating[4]Traditional · 1/10

Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety

Evidence: 1
Label: Bloating
Cancer (anticancer research)[6, 7, 12]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Headache[4]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Headache
Indigestion[4]Traditional · 1/10

Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety

Evidence: 1
Label: Indigestion
Infection (general)[4]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[4]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Liver support[4]Traditional · 1/10

inferred from choleretic action

Evidence: 1
Label: Liver support
Menstrual cramps[4]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Menstrual cramps
Muscle spasm[4]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Muscle spasm
Pain (general)[4]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Pain (general)
Skin irritation[4]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Warts[4]Traditional · 1/10

Fresh orange latex traditionally dabbed on warts

Evidence: 1
Label: Warts
Wounds[4]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Acid reflux[14, 15, 16]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Acid reflux
Arthritis / joint pain[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Back pain[14, 15, 16]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Back pain
Cancer (anticancer research)[2, 12]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Headache[14, 15, 16]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Headache
Indigestion[14, 15, 16]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Indigestion
Infection (general)[14, 15, 16]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Menstrual cramps[14, 15, 16]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Menstrual cramps
Muscle spasm[14, 15, 16]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Muscle spasm
Pain (general)[14, 15, 16]Traditional · 1/10
Evidence: 1
Label: Pain (general)
Skin irritation[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Swelling / fluid retention[14, 15, 16]Traditional · 1/10

inferred from diuretic action

Evidence: 1
Label: Swelling / fluid retention
Urinary support[14, 15, 16]Traditional · 1/10

inferred from diuretic action

Evidence: 1
Label: Urinary support
Urinary tract infection (UTI)[14, 15, 16]Traditional · 1/10

inferred from diuretic action

Evidence: 1
Label: Urinary tract infection (UTI)
Wounds[14, 15, 16]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds

Safety, Cautions & Contraindications

Safety note[13, 14]Serious

SERIOUS: oral greater celandine can cause acute idiosyncratic liver injury (hepatocellular hepatotoxicity with jaundice). Multiple reported cases - dozens of herb-induced liver injury reports in the literature, with continuing recent case reports - led regulators to restrict or suspend oral products. Do not take internally if you have any liver disease, and stop immediately and seek care at any sign of liver problems (jaundice, dark urine, upper-abdominal pain).

Safety note[4, 13]Caution

Avoid in pregnancy and breastfeeding. The fresh orange latex is irritant and caustic - keep it away from the eyes and broken skin.

Safety note[14, 15, 16]Caution

Generally safe in normal culinary and medicinal doses. Avoid in salicylate sensitivity or aspirin allergy. Not recommended for children with viral illnesses (Reye's syndrome risk, as with other salicylate-containing plants). Avoid during pregnancy and breastfeeding.

Safety note[14, 15, 16, 17]Caution

Duke (2002) rates meadowsweet as ++ and notes analgesic, antiulcer, antirheumatic, astringent, and anti-aggregant activities at the experimental level (score 1). The plant is historically significant as a precursor to aspirin — salicylate compounds in meadowsweet were originally used to derive acetylsalicylic acid. Unlike aspirin, meadowsweet's salicylates are combined with protective mucilaginous compounds that may reduce gastric irritation. Duke notes that individuals with aspirin (salicylate) sensitivity should avoid meadowsweet; the plant also has anticoagulant properties that may interact with blood-thinning medications (Duke, 2002).

External Ids

Gbif: 5334186
Wikidata: Q156807
Gbif: 2987999
Wikidata: Q147176

Botanical Description

Branching perennial herb with soft, brittle, hairy stems that exude a distinctive bright orange-yellow latex (sap) when cut or broken. The leaves are deeply lobed, pale bluish-green beneath, giving a delicate, almost fern-like appearance. Small, four-petalled, bright yellow flowers are borne in loose umbel-like clusters.[4]

Height: 30-90 cm
Habit: Branching, brittle-stemmed perennial herb
Leaves: Deeply lobed, pale bluish-green beneath
Flowers: Small, four-petalled, bright yellow, in loose umbel-like clusters
Stem: Soft, brittle, hairy, exuding bright orange-yellow latex when broken
Root: Branching taproot, also exuding orange latex
Fruit: Slender, curved capsule
Flowering Period: April-September

Tall, moisture-loving perennial herb with pinnately compound leaves, dark green above and whitish-downy beneath, the leaflets sharply toothed. Dense, fluffy, creamy-white flower clusters with a strong, sweet, almond-like fragrance are borne atop reddish, grooved stems.[1]

Height: 60-120 cm
Habit: Tall, erect, moisture-loving perennial herb
Leaves: Pinnately compound, dark green above, whitish-downy beneath, sharply toothed leaflets
Flowers: Dense, fluffy, creamy-white clusters with a strong sweet almond-like fragrance
Stem: Reddish, grooved, erect
Root: Fibrous roots from a short rhizome
Fruit: Small, spirally twisted achenes
Flowering Period: June-September

Habitat

Grows in shaded, nutrient-rich ground - hedgerows, walls, waste ground and woodland edges, often near old buildings; native to Europe and Western Asia and naturalised in North America.[4]

Grows in damp meadows, marshes, riverbanks, ditches and wet woodland margins; native to Europe and temperate Asia, favouring moist, nutrient-rich ground.[1]

Harvesting

The flowering aerial parts are cut in spring to summer; the fresh orange latex is collected by breaking a stem or leaf as needed for topical (wart) use. Given the documented hepatotoxicity of oral preparations, harvesting for internal use is not recommended.[4]

Parts: Aerial parts (and fresh orange latex)
Season: Spring to summer, while flowering

The flowering tops, leaf and stem are cut in summer as the flowers open, when the characteristic salicylate content is highest, and dried in a warm, shaded, airy place.[1]

Parts: Flower, Leaf, Stem
Season: Summer, at flowering

Traditional Uses

Greater celandine has a long European folk history, reflected in its name 'tetterwort', as a topical remedy for warts and skin blemishes (the fresh orange latex dabbed directly on), and internally as a bitter choleretic digestive remedy for biliary and upper-abdominal dyspepsia - though oral use is now medically restricted because of documented liver injury.[4]

Meadowsweet is historically significant as the plant from which salicylic acid derivatives (the chemical basis of aspirin) were first isolated, and has long been used in European folk medicine as an anti-inflammatory, analgesic and gastroprotective remedy for feverish colds, rheumatic and joint pain, and digestive complaints such as acid reflux and indigestion - notably, its natural mucilage is thought to buffer the gastric irritation associated with isolated salicylates.[1, 4]

Preparations

Fresh latex (topical, warts only)[4]

Fresh orange latex from a broken stem dabbed directly onto warts, the classic external folk use; kept well away from eyes, mucous membranes and broken skin.

Infusion/tincture (historical, oral - restricted)[13]

Historically taken as an infusion or tincture for biliary dyspepsia, but oral use is now restricted in several jurisdictions due to hepatotoxicity risk and should only be considered under professional supervision, if at all.

Infusion[1]

Dried flower, leaf and stem infused in hot water as a traditional anti-inflammatory and digestive tea.

Tincture[13]

Tincture (1:5) of the dried aerial parts; single dose 2-4 ml, daily dose 6-12 ml per the EU herbal monograph. Educational reference only, not a prescription.

Standardised extract[4]

Concentrated extract studied in vitro and in vivo for anti-inflammatory and gastroprotective activity.

Dosage

All internal preparations[13, 14]

Because of a documented risk of acute liver injury, no internal dose is given here; oral use should be avoided, especially by anyone with liver disease, and any sign of jaundice, dark urine or upper-abdominal pain warrants immediate medical attention. Educational reference only, not a prescription.

Infusion[13]

The EU herbal monograph gives a single dose of 1.5-6 g of the comminuted herb as an infusion, for a daily dose of 2-18 g, in adults and elderly; a powdered herbal substance at 250-500 mg per dose (250-1500 mg daily) and a 1:5 tincture at 2-4 mL per dose (6-12 mL daily) are also listed. Contraindicated in hypersensitivity to salicylates. For rheumatic-type complaints, not to be used for more than 4 weeks. Not recommended under 18 years. Educational reference only, not a prescription.

References

REF-0770, REF-0771, REF-0772, REF-0460, REF-2264, REF-2265, REF-2266, REF-2267, REF-2268, REF-2269, REF-2270, REF-2271
REF-0815, REF-0816, REF-0817, REF-2030, REF-2031, REF-2032, REF-2033, REF-2034, REF-2035, REF-2036, REF-2037, REF-2038

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Li, X.L., Sun, Y.P., Wang, M., Wang, Z.B. and Kuang, H.X (2024) 'Alkaloids in Chelidonium majus L.: a review of its phytochemistry, pharmacology and toxicology', Frontiers in Pharmacology, 15, pp. 1440979. doi:10.3389/fphar.2024.1440979 Traditional / reference
    https://doi.org/10.3389/fphar.2024.1440979
  2. Koriem, K.M.M., Arbid, M.S. and Asaad, G.F (2012) 'Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats', Journal of Natural Medicines, 67(1), pp. 159-167. doi:10.1007/s11418-012-0667-6 Preclinical
    https://doi.org/10.1007/s11418-012-0667-6
  3. Nawrot, R (2017) 'Defense-related Proteins from Chelidonium majus L. as Important Components of its Latex', Current Protein & Peptide Science, 18(8), pp. 864-880. doi:10.2174/1389203718666170406124013 Traditional / reference
    https://doi.org/10.2174/1389203718666170406124013
  4. Gilca, M., Gaman, L., Panait, E., Stoian, I. and Atanasiu, V (2010) 'Chelidonium majus - an integrative review: traditional knowledge versus modern findings', Forschende Komplementarmedizin. doi:10.1159/000321397 Traditional / reference
    https://doi.org/10.1159/000321397
  5. Popovic, A., Deljanin, M., Popovic, S., Todorovic, D., Djurdjevic, P., Matic, S., Stankovic, M., Avramovic, D. and Baskic, D (2021) 'Chelidonium majus crude extract induces activation of peripheral blood mononuclear cells and enhances their cytotoxic effect toward HeLa cells', International Journal of Environmental Health Research, 32(7), pp. 1554-1566. doi:10.1080/09603123.2021.1897534 Preclinical
    https://doi.org/10.1080/09603123.2021.1897534
  6. Shen, L., Lee, S.A., Joo, J.C., Hong, E., Cui, Z.Y., Jo, E., Park, S.J. and Jang, H.J (2022) 'Chelidonium majus induces apoptosis of human ovarian cancer cells via ATF3-mediated regulation of Foxo3a by Tip60', Journal of Microbiology and Biotechnology, 32(4), pp. 493-503. doi:10.4014/jmb.2109.09030 Preclinical
    https://doi.org/10.4014/jmb.2109.09030
  7. Deljanin, M., Nikolic, M., Baskic, D., Todorovic, D., Djurdjevic, P., Zaric, M., Stankovic, M., Todorovic, M., Avramovic, D. and Popovic, S (2016) 'Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines', Journal of Ethnopharmacology, 190, pp. 362-371. doi:10.1016/j.jep.2016.06.056 Preclinical
    https://doi.org/10.1016/j.jep.2016.06.056
  8. Warowicka, A., Qasem, B., Dera-Szymanowska, A., Wolun-Cholewa, M., Florczak, P., Horst, N., Napierala, M., Szymanowski, K., Popenda, L., Bartkowiak, G., Florek, E., Gozdzicka-Jozefiak, A. and Mlynarz, P (2021) 'Effect of protoberberine-rich fraction of Chelidonium majus L. on endometriosis regression', Pharmaceutics, 13(7), pp. 931. doi:10.3390/pharmaceutics13070931 Preclinical
    https://doi.org/10.3390/pharmaceutics13070931
  9. Kadan, G., Gozler, T. and Hesse, M (1992) '(+)-Norchelidonine from Chelidonium majus', Planta Medica, 58(5), pp. 477. doi:10.1055/s-2006-961523 Preclinical
    https://doi.org/10.1055/s-2006-961523
  10. Musidlak, O., Warowicka, A., Broniarczyk, J., Adamczyk, D., Gozdzicka-Jozefiak, A. and Nawrot, R (2022) 'The activity of Chelidonium majus L. latex and its components on HPV reveal insights into the antiviral molecular mechanism', International Journal of Molecular Sciences, 23(16), pp. 9241. doi:10.3390/ijms23169241 Preclinical
    https://doi.org/10.3390/ijms23169241
  11. Zhang, W., You, C., Wang, C., Fan, L., Wang, Y., Su, Y., Deng, Z. and Du, S (2014) 'One new alkaloid from Chelidonium majus L', Natural Product Research, 28(21), pp. 1873-1878. doi:10.1080/14786419.2014.953497 Preclinical
    https://doi.org/10.1080/14786419.2014.953497
  12. Capistrano I, R., Wouters, A., Lardon, F., Gravekamp, C., Apers, S. and Pieters, L (2015) 'In vitro and in vivo investigations on the antitumour activity of Chelidonium majus', Phytomedicine, 22(14), pp. 1279-1287. doi:10.1016/j.phymed.2015.10.013 Preclinical
    https://doi.org/10.1016/j.phymed.2015.10.013
  13. Teschke, R., Frenzel, C., Glass, X., Schulze, J. and Eickhoff, A (2012) 'Greater Celandine hepatotoxicity: a clinical review', Annals of Hepatology. doi:10.1016/s1665-2681(19)31408-5 Clinical study
    https://doi.org/10.1016/s1665-2681(19)31408-5
  14. Ciornolutchii, V., Ismaiel, A., Sabo, C.M., Al Hajjar, N., Seicean, A. and Dumitrascu, D.L (2024) 'A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L. Report of Two Cases of Herb-Induced Liver Injury and Literature Review', American Journal of Therapeutics, 31(4), pp. e382--e387. doi:10.1097/MJT.0000000000001708 Clinical study
    https://doi.org/10.1097/MJT.0000000000001708
  1. Samardžić, S., Arsenijević, J., Božić, D., Milenković, M. et al (2017) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
    https://doi.org/10.1016/j.jep.2017.11.013
  2. Andonova, T., Muhovski, Y., Apostolova, E., Naimov, S. et al (2024) 'DNA-Protective, Antioxidant and Anti-Carcinogenic Potential of Meadowsweet (Filipendula ulmaria) Dry Tincture', Antioxidants (Basel), 13(10), pp. 1200. doi:10.3390/antiox13101200 Preclinical
    https://doi.org/10.3390/antiox13101200
  3. Van der Auwera, A., Peeters, L., Foubert, K., Piazza, S. et al (2023) 'In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria', Pharmaceutics, 15(4), pp. 1291. doi:10.3390/pharmaceutics15041291 Preclinical
    https://doi.org/10.3390/pharmaceutics15041291
  4. Katanic, J., Boroja, T., Mihailovic, V., Nikles, S., Pan, S., Rosic, G., Selakovic, D., Joksimovic, J., Mitrovic, S. and Bauer, R (2016) 'In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent', Journal of Ethnopharmacology, 193, pp. 627-636. doi:10.1016/j.jep.2016.10.015 Preclinical
    https://doi.org/10.1016/j.jep.2016.10.015
  5. Samardzic, S., Tomic, M., Pecikoza, U., Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
    https://doi.org/10.1016/j.jep.2016.10.024
  6. Katanic, J., Matic, S., Pferschy-Wenzig, E., Kretschmer, N., Boroja, T., Mihailovic, V., Stankovic, V., Stankovic, N., Mladenovic, M., Stanic, S., Mihailovic, M. and Bauer, R (2016) 'Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis', Food and Chemical Toxicology, 99, pp. 86-102. doi:10.1016/j.fct.2016.11.018 Preclinical
    https://doi.org/10.1016/j.fct.2016.11.018
  7. Arsenijevic, N., Selakovic, D., Katanic Stankovic, J.S., Mihailovic, V., Mitrovic, S., Milenkovic, J., Milanovic, P., Vasovic, M., Nikezic, A., Milosevic-Djordjevic, O., Zivanovic, M., Filipovic, N., Jakovljevic, V., Jovicic, N. and Rosic, G (2021) 'Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus', Journal of Integrative Neuroscience, 20(4), pp. 871-883. doi:10.31083/j.jin2004089 Preclinical
    https://doi.org/10.31083/j.jin2004089
  8. Matic, S., Katanic, J., Stanic, S., Mladenovic, M., Stankovic, N., Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
    https://doi.org/10.1016/j.jep.2015.08.025
  9. Pannakal, S.T., Eilstein, J., Hubert, J., Kotland, A., Prasad, A., Gueguiniat-Prevot, A., Juchaux, F., Beaumard, F., Seru, G., John, S. and Roy, D (2023) 'Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS', Molecules, 28(17), pp. 6349. doi:10.3390/molecules28176349 Preclinical
    https://doi.org/10.3390/molecules28176349
  10. Valle, M.G., Nano, G.M. and Tira, S (1988) 'The Essential Oil of Filipendula ulmaria', Planta Medica, 54(2), pp. 181-182. doi:10.1055/s-2006-962390 Preclinical
    https://doi.org/10.1055/s-2006-962390
  11. Popowski, D., Zentek, J., Piwowarski, J.P. and Granica, S (2021) 'Gut Microbiota of Pigs Metabolizes Extracts of Filipendula ulmaria and Orthosiphon aristatus - Herbal Remedies Used in Urinary Tract Disorders', Planta Medica, 88(3-04), pp. 254-261. doi:10.1055/a-1647-2866 Preclinical
    https://doi.org/10.1055/a-1647-2866
  12. Bespalov, V.G., Alexandrov, V.A., Semenov, A.L., Kovan'ko, E.G., Ivanov, S.D., Vysochina, G.I., Kostikova, V.A. and Baranenko, D.A (2016) 'The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats', International Journal of Radiation Biology, 93(4), pp. 394-401. doi:10.1080/09553002.2016.1257834 Preclinical
    https://doi.org/10.1080/09553002.2016.1257834
  13. European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf
  14. Bridge, J (2008) 'The Herbal Remedy Handbook'. Traditional / reference
    https://scholar.google.com/scholar?q=The%20Herbal%20Remedy%20Handbook
  15. Drummond, E.M., Harbourne, N., Marete, E., Jacquier, J.C., O'Riordan, D. and Gibney, E.R (2013) 'Inhibition of pro-inflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark', 27(4), pp. 588--594. Traditional / reference
    https://scholar.google.com/scholar?q=Inhibition%20of%20pro-inflammatory%20biomarkers%20in%20THP1%20macrophages%20by%20polyphenols%20derived%20from%20chamomile%2C%20meadowsweet%20and%20willow%20bark
  16. Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
    https://scholar.google.com/scholar?q=A%20Modern%20Herbal
  17. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.